Adage Capital Partners Gp, L.L.C. Design Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$9.91 - $17.33 $991,000 - $1.73 Million	100,000 Added 50.0%	300,000 $4.2 Million
Q1 2022 May 16, 2022	BUY	$11.17 - $20.89 $390,950 - $731,150	35,000 Added 21.21%	200,000 $3.23 Million
Q3 2021 Nov 15, 2021	BUY	$13.99 - $20.03 $1.68 Million - $2.4 Million	119,888 Added 265.76%	165,000 $2.42 Million
Q2 2021 Aug 16, 2021	SELL	$19.02 - $29.78 $2.95 Million - $4.61 Million	-154,888 Reduced 77.44%	45,112 $897,000
Q1 2021 May 17, 2021	BUY	$29.52 - $41.49 $5.9 Million - $8.3 Million	200,000 New	200,000 $5.98 Million

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $252M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.